Dr. Julliet M. has had a diverse work experience. Dr. Julliet started their career in 2011 as a Medical Doctor at the Ministry of Health. Dr. Julliet then pursued postgraduate studies at Hebrew University, where they obtained a Masters Degree in Medical Doctor studies. Following that, they worked as a Reproductive Health Advisor & Project Coordinator at the United Nations Population Fund (UNFPA) from February 2015 to April 2016. Dr. M. then joined the World Health Organization as a Public Health Specialist (Physician) from April 2016 to April 2019. Dr. Julliet later joined MSD Switzerland as a Senior Study Manager from December 2020 to October 2022. Currently, they hold the position of Associate Director, Oncology Value Evidence & Medical Affairs; Regulatory Affairs special assignment at MSD Switzerland, starting in November 2022.
Dr. Julliet M. has an extensive education history. Dr. Julliet obtained their Master of Advanced Studies in Drug Discovery & Clinical Development from the University of Geneva, attending from 2019 to 2021. Prior to that, they pursued their Masters in Public Health (MPH) in Epidemiology at The Hebrew University of Jerusalem from 2013 to 2014.
Furthermore, Dr. Julliet M. holds a Medical Doctor degree in Medicine & Surgery, which they earned from Moi University between 2005 and 2010.
In addition to their educational qualifications, Dr. Julliet M. has acquired several certifications. Dr. Julliet received the BoardLearn Certified-Board Member Boot Camp certification from Cause Strategy Partners in December 2022. Dr. Julliet also holds a GCP-E6(R2) 2016 Certificate from TRREE, obtained in May 2019.
Strengthening their qualifications, Dr. Julliet M. possesses two PRINCE2 certifications. Dr. Julliet completed the PRINCE2® 2017 Practitioner training through AXELOS Global Best Practice in April 2019, along with the PRINCE2® Foundation Certification Training in March of the same year.
Additionally, they obtained their Medical Doctor certification from the Kenya Medical Practitioners and Dentists' Board in January 2011.
Sign up to view 0 direct reports
Get started